
Opinion|Videos|May 8, 2025
Optimizing Multidisciplinary Coordination for Successful Tarlatamab Implementation
Panelists discuss how optimizing tarlatamab administration requires effective multidisciplinary team collaboration, with oncology, pharmacy, neurology, and nursing coordinating on treatment plans, patient monitoring, and adverse event management to ensure consistent, comprehensive care.
Advertisement
Episodes in this series

Summary for Physicians:
Optimizing Coordination for Tarlatamab Administration:
- Multidisciplinary Team (MDT) Collaboration:
- Regular communication between oncology, pharmacy, neurology, and nursing to align on treatment plans.
- Shared care protocols to ensure consistency in patient monitoring, especially for immune-related adverse effects.
- Joint decision-making for pretreatment screening and addressing adverse events promptly.
- Pharmacy Role:
- Ensure proper drug handling and dosing protocols are followed.
- Support with timely drug availability and managing potential supply chain issues.
- Neurology Input:
- Monitor for any neurological symptoms (eg, seizures, encephalopathy) and adjust management as needed.
General Approach:
- Establish clear workflows for patient care, from infusion to follow-up, ensuring all team members are aware of each stage of treatment.
Encourage routine MDT meetings to review patient progress and adapt as necessary.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Adjuvant Cemiplimab in Cutaneous Squamous Cell Carcinoma
2
Cryoablation Regimen Receives FDA Marketing Authorization for Breast Cancer
3
Adjuvant Endocrine/Radiation Therapy May Limit Breast Cancer Recurrence
4
Managing BCMA/GPRC5D-Associated CRS and ICANS in the Real-World Setting
5